Skip to main content
. 2014 Sep 3;105(9):1093–1099. doi: 10.1111/cas.12484

Fig 3.

Fig 3

Frequency of TET2 mutation in various hematological malignancies. AITL, angioimmunoblastic T-cell lymphoma; AML, acute myeloid leukemia; CMML, chronic myelomonocytic leukemia; DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm; PTCL-NOS, peripheral T-cell lymphoma, not otherwise specified; T-LBL, T-lymphoblastic lymphoma.